| Literature DB >> 31470508 |
Komal Rizwan1,2, Shakeel Ahmad Khan3, Ikram Ahmad4, Nasir Rasool5, Muhammad Ibrahim6, Muhammad Zubair5, Hawa Ze Jaafar7, Rosana Manea8.
Abstract
Viola betonicifolia (Violaceae) is commonly recognized as "Banafsha" and widely distributed throughout the globe. This plant is of great interest because of its traditional, pharmacological uses. This review mainly emphases on morphology, nutritional composition, and several therapeutic uses, along with pharmacological properties of different parts of this multipurpose plant. Different vegetative parts of this plant (roots, leaves, petioles, and flowers) contained a good profile of essential micro- and macronutrients and are rich source of fat, protein, carbohydrates, and vitamin C. The plant is well known for its pharmacological properties, e.g., antioxidant, antihelminthic, antidepressant, anti-inflammatory, analgesic, and has been reported in the treatment of various neurological diseases. This plant is of high economic value. The plant has potential role in cosmetic industry. This review suggests that V. betonicifolia is a promising source of pharmaceutical agents. This plant is also of significance as ornamental plant, however further studies needed to explore its phytoconstituents and their pharmacological potential. Furthermore, clinical studies are needed to use this plant for benefits of human beings.Entities:
Keywords: Viola betonicifolia; antioxidant; antipyretic; bioactive constituents; extraction; isolated; nutrients; techniques
Year: 2019 PMID: 31470508 PMCID: PMC6749243 DOI: 10.3390/molecules24173138
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Different parts of plant V. betonicifolia: L., leaf; F., flower; S, seed.
Quantitative leaf microscopy.
| Morphological Features | Range | Means |
|---|---|---|
| Palisade-ratio | 9–8.25 | 8.62 ± 0.23 |
| Stomata number (upper epidermis) | 12–19 | 16.70 ± 0.31 |
| Epidermal cells (upper epidermis) | 52–73 | 60.70 ± 0. 39 |
| Stomata number (lower epidermis) | 54–62 | 55.23 ± 0.28 |
| Epidermal cells (lower epidermis) | 142–154 | 140.12 ± 0.43 |
| Vein islet number | 7.5–10 | 8.40 ± 0.25 |
| Veinlet termination number | 5–6 | 5.50 ± 0.11 |
Data Source: Muhammad et al., [23].
Micro- and macronutrients in different parts of V. betonicifolia.
|
| |||||||
|
|
|
|
|
|
|
|
|
|
| 6.45 ± 0.21 | 23.90 ± 0.22 | 40 ± 0.15 | 320 ± 0.33 | 14 ± 0.11 | --- | 10 ± 0.15 |
|
| 5.63 ± 0.23 | 15.56 ± 0.11 | 20 ± 0.17 | 340 ± 0.20 | 9 ± 0.22 | 0.50 ± 0.11 | 34 ± 0.26 |
|
| --- | 42.67 ± 0.26 | 67 ± 0.20 | 295 ± 0.19 | 3 ± 0.02 | --- | 28 ± 0.02 |
|
| 1.34 ± 0.26 | 40.89 ± 0.27 | 50 ± 0.10 | 220 ± 0.31 | 27 ± 0.25 | 1.00 ± 0.17 | 36 ± 0.22 |
|
| 7.23 ± 0.32 | 80.45 ± 0.22 | 35 ± 0.19 | 245 ± 0.45 | 60 ± 0.22 | 1.20 ± 0.30 | 50 ± 0.25 |
|
| |||||||
|
|
|
|
| ||||
|
| 156.00 ± 0.12 | 890.00 ± 0.26 | 132.00 ± 0.12 | ||||
|
| 623.00 ± 0.32 | 325.00 ± 0.11 | 256.00 ± 0.24 | ||||
|
| 214.00 ± 0.38 | 235.00 ± 0.40 | 134.00 ± 0.11 | ||||
|
| 124.00 ± 0.44 | 170.00 ± 0.56 | 200.00 ± 0.38 | ||||
|
| 723.00 ± 0.51 | 191.00 ± 0.122 | 500.00 ± 0.32 | ||||
Data source: Muhammad et al., [22].
Figure 2Isolated bioactive constituents of V. betonicifolia: 2,4-dihydroxy, 5-methoxy-cinnamic acid (1), 3-methoxydalbergione (2), and 4-hydroxy coumarin (3).
Pharmacological activities of whole V. betonicifolia Plant.
| Sr # | Pharmacological Activity | Model | Assay | Extract/Fraction/Compounds | Extraction Technique Used | Outcome/Response | Reference |
|---|---|---|---|---|---|---|---|
| 1 |
| In vitro | agar well diffusion method | Methanolic, | Maceration and fractionation at room temp. | chloroform fraction showed zone of inhibition against | [ |
|
| agar well diffusion method | Subfractions F1-F6 | Maceration and fractionation at room temp. | No activity observed | [ | ||
|
|
| Disc diffusion method | Methanolic, n-hexane, chloroform, ethyl acetate, | Maceration and fractionation at room temp. | % inhibition of methanolic extract against | [ | |
|
| Disc diffusion method | Subfractions F1-F6 | Maceration at room temp. | Potential inhibition effect against all strains was observed | [ | ||
| 2 |
| In vitro | Total phenolic contents | ethylacetate, methanol, chloroform, butanol, Aqueous | Maceration and fractionation at room temp. | chloroform = 62.0 mg/g, methanol = 34.0 mg/g, ethyl acetate = 64.13 mg/g, butanol = 28.32 mg/g, aqueous (6.46 mg/g) | [ |
| DPPH radical scavenges assay | ethylacetate, methanol, chloroform, butanol, Aqueous, | IC50 values of different extracts and fractions, chloroform = 80 μg/m, ethyl acetate = 82 μg/m, methanol = 110 μg/m, | |||||
| Total flavonoid contents | ethylacetate, methanol, chloroform, butanol, Aqueous | Ethyl acetate = 65.36 mg/g, methanol = 39.0 mg/g, chloroform = 63.89 mg/g, | |||||
| 3 |
|
| methanolic chloroform, | Maceration and fractionation at room temp. | Dose and time-dependent mortality effect was observed. | [ | |
|
|
| Methanolic extract | Maceration and fractionation at room temp. | Chloroform fraction showed LC50 = 13.03 μg/mL, followed by ethyl acetate and methanolic extract 16.00 and 61.30 μg/mL respectively | [ | ||
|
| Methanolic extract | Maceration and fractionation at room temp. | Time and dose-dependent effect was observed | [ | |||
|
|
| Methanolic extract | Maceration and fractionation at room temp. | IC50 > 100 μg/mL No activity observed | [ | ||
| 4 |
| Phytotoxic activity |
| Methanolic extract | Maceration and fractionation at room temp. | The outstanding phytotoxic effects were observed against | [ |
| F1-F6 subfractions | F1, F3, and F6 showed concentration-dependent phytotoxic effect. All other subfractions showed weak effect. | [ | |||||
| Cytotoxic activity | Brine shrimp lethality assay | Methanolic extract | Maceration and fractionation at room temp. | Concentration-dependent effect was observed. Aqueous = LC50 46 μg/mL and chloroform = LC50 56 μg/mL | [ | ||
| F1–F6 subfractions | F5 and F6 (LD50 = 175.4 and 160.7 μL/mL) showed significant cytotoxic effects. F4 did not showed any cytotoxic activity while F1, F2, and F3 showed weak cytotoxic effect. | [ | |||||
| 5 |
| In vivo | Staircase test | methanolic extract | Maceration and fractionation at room temp. | Significant Dose-dependent effect observed | [ |
| In vivo | Chimney test, Traction test, Rota rod, and Inclined plane | Significant Dose-dependent effect observed | |||||
| In vivo | Hypnotic test and sedative test | ||||||
| 6 |
| In vivo | Brewers-induced pyrexia | Methanol extract | Maceration and fractionation at room temp. | methaolic extract = 78.23%, | [ |
| 7 |
| In vivo | Forced swimming test (FST) | Maceration and fractionation at room temp. | No antidepressant effect | [ | |
| locomotor activity by line crossing test | No antidepressant effect | ||||||
| 8 |
| In vivo | Acetic acid induced writhing test | Methanolic extract | Maceration and fractionation at room temp. | In acetic acid induced analgesia, methanolic extract and | [ |
| Tail immersion test | Significant analgesic effect observed | ||||||
| Hot plate test | Significant analgesic effect was observed | ||||||
| 9 |
| In vivo | PTZ induced seizures | n-hexane fraction | Maceration and fractionation at room temp. | Dose-dependent effect observed. No mortality observed | [ |
| strychnine induced convulsions | No activity, all mice died | ||||||
| 10 |
| In vivo | carrageen induced edema | Methanolic extract | Maceration and fractionation at room temp. | Dose-dependent effect was observed | [ |
| 11 |
| In vivo | Methanolic extract | Maceration and fractionation at room temp. | Methnolic extract showed mild diuretic effect but statistically nonsignificant | [ | |
| 12 |
| In vivo | spasmogenic effect | Methanolic extract | Maceration and fractionation at room temp. | The crude methanolic extract showed partially atropine-sensitive prokinetic (50 and 100 mg/kg) and laxative (30 and 100 mg/kg) effects | [ |
| In vitro studies on isolated rabbit jejunum and guinea pig ileum | Methanolic extract showed dose-dependent contractions. The spasmodic effect of methanolic extract was more efficacious in guinea pig ileum than rabbit jejunum preparation. | ||||||
| 13 |
| In vitro | methanolic extract | Maceration and fractionation at room temp. | Methanolic extract showed 20 and 40% activity against | [ | |
| subfractions (F1–F6) | significant effect observed | [ |
Effect of methanolic extract and n-hexane fraction on phenobarbitone-induced sleep in mice.
| Treatment | Dose | Onset of Sleep (Min) | Duration of Sleeping (Min) |
|---|---|---|---|
| Distilled water | 10 mL/kg | 25.12 ± 1.25 | 7.34 ± 2.28 |
| Diazepam | 4 mg/kg | 5.45 ± 0.08 | 56.45 ± 0.00 |
| 0.3 g/kg | 30.45 ± 1.97 | 5.13 ± 0.99 | |
| 0.4 g/kg | 13.79 ± 1.98 | 18.08 ± 0.76 | |
| 0.5 g/kg | 9.08 ± 1.01 | 30.03 ± 1.98 | |
| Methanolic extract | 0.3 g/kg | 23.45 ± 0.87 | 8.13 ± 0.97 |
| 0.4 g/kg | 15.78 ± 0.78 | 13.98 ± 1.76 | |
| 0.5 g/kg | 10.98 ± 0.91 | 25.23 ± 1.46 |
All animal groups were treated with phenobarbitone (35 mg/kg). Data presented as mean ± SEM (n = 6).
Antidepressant activity of n-hexane fraction of V. betonicifolia whole-plant.
| Treatment | Dose | Immobility Time (s) |
|---|---|---|
| Distilled water | 10 mL/kg | 110 ± 0.09 |
| 0.3 mg | 157 ± 1.07 | |
| 0.4 mg | 206 ± 1.72 | |
| 0.5 mg | 215 ± 0.93 | |
| Fluoxetine | 15 mg | 30.34 ± 0.00 |
Values represent the time of immobility (s) in the forced swimming bath for 6 min. Data presented as mean ± SEM (n = 6).
Chemical composition of volatile oils (subfractions F1–F6) of V. betonicifolia.
| Sr# | Compound | % Area | ||||||
|---|---|---|---|---|---|---|---|---|
| F1 | F2 | F3 | F4 | F5 | F6 | Retention Time | ||
| 1 | 3-Hexanone | - | - | - | 1.48 | - | - | 4.48 |
| 2 | 2-Hexanone | - | - | - | 2.01 | - | - | 4.59 |
| 3 | Heptane | - | - | - | 3.35 | - | - | 5.38 |
| 4 | Dimethyl-1-heptene | - | - | - | 2.68 | - | - | 5.9 |
| 5 | Octane-4-methyl | - | - | - | 1.6 | - | - | 6.5 |
| 6 | 4-Methyldecane | - | - | - | 1.4 | - | - | 10.74 |
| 7 | Dodecane | - | - | - | 1.03 | - | - | 11.95 |
| 8 | Dimethylnonane | - | - | - | 6.11 | - | - | 12.1 |
| 9 | 1-Decanol | - | - | - | 1.7 | - | - | 12.5 |
| 10 | Tricosane | - | - | - | 1.03 | - | - | 13.2 |
| 11 | 3,8-Dimethyl undicane | - | - | - | 1.5 | - | - | 17.11 |
| 12 | Pentadecane | - | - | - | 1.8 | 2.7 | - | 17.4 |
| 13 | 4,6-Dimethyldodecane | - | - | - | 1.99 | - | - | 17.9 |
| 14 | 1-Octadecanol | - | - | - | 1.46 | - | - | 18.09 |
| 15 | Tetradecane | - | - | - | 2.2 | 1.15 | - | 20.15 |
| 16 | Tetracosane | - | - | - | 1.03 | - | - | 21.5 |
| 17 | Docosane | - | - | - | 1.7 | - | - | 22.3 |
| 18 | Cyclohexadecane | - | - | 4.35 | 3.2 | - | - | 22.5 |
| 19 | 2,4-Di-tert-butyl phenol | 4.13 | 3.76 | - | - | 10.6 | - | 22.51 |
| 20 | Tritriacontane | - | - | - | 8.9 | - | - | 22.74 |
| 21 | Octylether | - | - | - | 2.6 | - | - | 22.90 |
| 23 | Tetramethylhexadecane | - | - | - | 9.8 | - | - | 23.27 |
| 24 | Tetradecanol | - | 6.42 | - | 4.3 | - | 24.06 | |
| 25 | Hexadecane | - | 3.15 | 1.89 | 1.5 | 21.74 | - | 24.2 |
| 26 | Nonadecane | - | - | - | 2.78 | - | - | 24.8 |
| 27 | Trimethylpentadecane | - | - | - | 100 | - | - | 25.1 |
| 28 | t-Butyl 7-Methyl-3,5-dioxo-6-octenoate | - | - | - | 14.89 | - | - | 25.27 |
| 29 | Oxalic acid, 6-ethyloct-3-yl isobutylester | - | - | - | 4.61 | - | - | 27.0 |
| 30 | Eicosane, 3-phenyl | - | - | - | 1.75 | - | - | 27.32 |
| 31 | 9-Methylene-fluorene | - | - | - | 1.17 | - | - | 27.32 |
| 32 | 1.41 | - | - | - | - | - | 27.73 | |
| 33 | Octadecane | - | 2.5 | 2.24 | - | 1.43 | - | 27.85 |
| 34 | Methyl laurate | - | 10 | - | - | 28.3 | ||
| 35 | Neophytadiene | 5.54 | 11.52 | 1.11 | - | 2.39 | - | 28.53 |
| 36 | 2-Pentadecanone trimethyl | - | - | - | 10 | - | - | 28.46 |
| 37 | Hexahydrofarnesyl acetone | - | - | 1.09 | - | - | - | 28.64 |
| 38 | 2-Benzenedicarboxylic | - | - | - | - | - | 3.77 | 29.07 |
| 39 | 9-Hexadecanoic acid, methyl ester | 5.96 | - | - | - | - | - | 29.63 |
| 40 | Methylhexadec-9-enoate | - | - | 11.92 | - | - | - | 29.64 |
| 41 | Methyl-palmitoleate | - | 2.88 | - | - | 2.5 | - | 29.92 |
| 42 | Methyl palmitate | - | - | 14.79 | - | 5.17 | - | 29.98 |
| 43 | Methyl 10-methyldodecanate | 10 | - | - | - | - | - | 29.98 |
| 44 | Methyl tridecanoate | - | 1.44 | - | - | - | - | 30.04 |
| 45 | 1 Eicosanol | 1.15 | - | - | - | - | - | 31.06 |
| 46 | Chlorphyrifos | - | 2.79 | - | - | - | - | 31.13 |
| 47 | Eicosane | - | 6.17 | 16.74 | 6.32 | 2.24 | - | 31.16 |
| 48 | 2- Ethyl-1-dodecene | - | - | 3.2 | - | - | - | 31.29 |
| 49 | Methyl myristate | 34.94 | 3.65 | - | - | - | - | 31.58 |
| 50 | Methyl linoleate | 4.7 | - | - | - | - | - | 32.65 |
| 51 | Methyl oleate | 3.62 | 1.63 | - | - | - | 32.73 | |
| 52 | 9,12,15-Octadecatrienoic | - | - | 11.37 | - | - | - | 32.77 |
| 53 | Methyl pentadecanoate | 1.34 | - | - | - | - | 33.12 | |
| 54 | 1-Tridecanol | - | 1.1 | - | - | - | 33.51 | |
| 55 | Arachic alcohol | 3.15 | 10.6 | 10.0 | - | - | 34.11 | |
| 56 | n-Heneicocane | - | - | 9.45 | 85.87 | - | - | 34.18 |
| 57 | 7-ethyl-6,8 dioxabicyclo [3.2.1]-oct-3-ene | - | - | - | - | - | 10 | 38.96 |
Figure 3Major components identified in volatile oils (subfractions F1–F6) of V. betonicifolia.